Qinhuangdao Huixianpu Medical System Co., Ltd. is a high-tech enterprise specializing in the design, development, production and sales of medical equipment and systems in biomedical field. The company has more than 50 professional R&D talents in the biomedical field. We have established long-term and stable cooperative relations with many biomedical research institutions, universities and 3A hospitals at home and abroad, and set up an academician workstation for electromagnetic interference and electrostatic protection, a biomedical research center and a biomedical experience center.
Focusing on the strategic policy of national population and health science and technology development, Huisipu Medical System Co., Ltd. strives to open up its own growth space in the development of national health management industry, and has successively developed "full chain" appropriate technical equipment for health management, such as early screening and health risk assessment of HRA disease, early screening and diagnosis of ADDS Alzheimer's disease, ADTS memory impairment training system, and PMR pulse magnetic vibration microcirculation repair. HRA disease early screening and health risk assessment system is radiation-free, non-invasive and non-invasive, which can quickly and accurately detect the potential risks of human body, creating a precedent for biomedical application in clinical and physical examination. Its technology has reached the international advanced level, and it has become the "blueprint product" of "Intelligent Medical Products-Health Risk Assessment System (HRA) Information Index (IQ) Evaluation Standard" of China Low-carbon Product Informatization Promotion Committee, and was invited. On September 20 12, HRA obtained the national medical device product registration certificate; 201March 25th19th-25th "2013rd Beijing Science and Technology Week Large-scale Popular Science Expo", and participated in the 20th/kloc-0 held on July 5th-9th, 20th13rd on behalf of the achievements of medical device technology development in China during the 11th Five-Year Plan period. The "Approaching Science" column of CCTV's science and education channel made a special news report on HRA with the title of "Good Helper for Health".
At present, the users of Huixianpu products have spread all over 25 provinces, cities and districts in China. Weisanpu Medical System Co., Ltd. has formed a strategic partnership with China Health Promotion Foundation, Tsinghua University and Peking University, and jointly launched a health management project with HRA application research and national health cloud data plan as the core content in China, which has accelerated the promotion of HRA in the national health management demonstration base and its flagship units, universities and sports systems. In order to meet the needs of continuous extension and development of the product line, Huixianpu Qinhuangdao production base covering an area of 50 mu has been built and put into use.